With the highest attending rate of academics, TTOs and research institutions, BioFIT is the place where academia-industry collaborations get started. BioFIT has taken on a whole new dimension becoming the meeting point in Europe for tech transfer and for sourcing early-stage innovations stemming from public research institutions, academic spin-offs and emerging biotech companies. Together with big pharma, biotech and diagnostics companies, BioFIT operates as a platform to build partnerships for all public and private actors. BioFIT is also the marketplace for seed and Series A investment in Life Sciences.

>> SIGN UP NOW FOR BIOFIT 2018 AND SAVE UP TO €240: Register now!

>> LIMITED NUMBER OF STANDS: Contact us to book a booth!

WHY ATTEND BIOFIT?
Out of 1,000 BioFIT attendees, 1,000 deals have been generated. The breakdown in terms of nature of deals is the following:

  • 35% of collaborative research projects
  • 30% of licensing deals
  • 15% of equity investment deals
  • 20% of services deals

Estimate based on the measurement of 2015 and 2016 delegates’ outcomes

NEW! Would-be CEO Platform
Are you a bioentrepreneur seeking a project? Or do you have projects seeking CEO?

Attend BioFIT by using the partnering platform and identify your future project or your future CEO.


Public & Private Collaborations

  • Entail new partnerships
  • Source innovative and competitive early stage R&D projects
  • Facilitate the emergence of collaborative projects
  • Increase licensing opportunities

Who will you meet?

TTOs / Research institutes / Academia 30%
Pharma / Diagnostics companies 20%
Biotech companies 20%
Preclinical CROs 15%
Investors 10%
Professional services & consulting 5%
CEO / VP / Managing Director 35%
Business Development 21%
R&D Researcher / Scientist 16%
Partnering / Licensing / Scouting / TTO 14%
Other 14%